Published in Cancer Res on June 09, 2009
DNA hypomethylation in cancer cells. Epigenomics (2009) 3.71
Epigenetics and colorectal cancer. Nat Rev Gastroenterol Hepatol (2011) 3.15
Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells. PLoS One (2010) 2.55
Molecular distinctions between stasis and telomere attrition senescence barriers shown by long-term culture of normal human mammary epithelial cells. Cancer Res (2009) 2.28
TGF-beta signaling engages an ATM-CHK2-p53-independent RAS-induced senescence and prevents malignant transformation in human mammary epithelial cells. Proc Natl Acad Sci U S A (2011) 1.94
Modeling initiation of Ewing sarcoma in human neural crest cells. PLoS One (2011) 1.48
Epigenetic regulation of normal human mammary cell type-specific miRNAs. Genome Res (2011) 1.27
Promoter methylation and the detection of breast cancer. Cancer Causes Control (2009) 1.18
miRNA gene promoters are frequent targets of aberrant DNA methylation in human breast cancer. PLoS One (2013) 1.17
Hepatitis B virus infection and the risk of hepatocellular carcinoma. World J Gastroenterol (2011) 1.14
Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations. Cell Cycle (2014) 1.05
Mitochondrial and plasma membrane lactate transporter and lactate dehydrogenase isoform expression in breast cancer cell lines. Physiol Genomics (2010) 1.03
Monomethylarsonous acid produces irreversible events resulting in malignant transformation of a human bladder cell line following 12 weeks of low-level exposure. Toxicol Sci (2010) 1.01
Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways. Oncogene (2012) 1.00
Chromatin remodeling in mammary gland differentiation and breast tumorigenesis. Cold Spring Harb Perspect Biol (2010) 0.98
Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia. Epigenetics (2012) 0.98
Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island. BMC Cancer (2013) 0.97
Arsenicals produce stable progressive changes in DNA methylation patterns that are linked to malignant transformation of immortalized urothelial cells. Toxicol Appl Pharmacol (2009) 0.94
TRIM24 links glucose metabolism with transformation of human mammary epithelial cells. Oncogene (2014) 0.93
Processing of human reduction mammoplasty and mastectomy tissues for cell culture. J Vis Exp (2013) 0.92
Epigenetic reprogramming of breast cancer cells with oocyte extracts. Mol Cancer (2011) 0.90
Alcohol consumption in relation to aberrant DNA methylation in breast tumors. Alcohol (2010) 0.90
DNA Methylation Fluctuation Induced by Virus Infection Differs between MD-resistant and -susceptible Chickens. Front Genet (2012) 0.88
Epigenetic reprogramming governs EcSOD expression during human mammary epithelial cell differentiation, tumorigenesis and metastasis. Oncogene (2013) 0.88
Role of gene methylation in antitumor immune response: implication for tumor progression. Cancers (Basel) (2011) 0.87
Detection of aberrant methylation of a six-gene panel in serum DNA for diagnosis of breast cancer. Oncotarget (2016) 0.86
Role of RNA binding protein HuR in ductal carcinoma in situ of the breast. J Pathol (2011) 0.85
Breast cancer genomes--form and function. Curr Opin Genet Dev (2010) 0.85
Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesis. Breast Cancer Res (2012) 0.84
Agglomerates of aberrant DNA methylation are associated with toxicant-induced malignant transformation. Epigenetics (2012) 0.84
Exome-wide mutation profile in benzo[a]pyrene-derived post-stasis and immortal human mammary epithelial cells. Mutat Res Genet Toxicol Environ Mutagen (2014) 0.83
Cell-type specific DNA methylation patterns define human breast cellular identity. PLoS One (2012) 0.82
Age and the means of bypassing stasis influence the intrinsic subtype of immortalized human mammary epithelial cells. Front Cell Dev Biol (2015) 0.82
Constitutive CCND1/CDK2 activity substitutes for p53 loss, or MYC or oncogenic RAS expression in the transformation of human mammary epithelial cells. PLoS One (2013) 0.82
A lincRNA connected to cell mortality and epigenetically-silenced in most common human cancers. Epigenetics (2015) 0.82
FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin silencing in breast cancer. Oncogene (2014) 0.81
Epigenetic changes during cell transformation. Adv Exp Med Biol (2013) 0.81
Fundamental differences in promoter CpG island DNA hypermethylation between human cancer and genetically engineered mouse models of cancer. Epigenetics (2013) 0.81
Coordinated epigenetic remodelling of transcriptional networks occurs during early breast carcinogenesis. Clin Epigenetics (2015) 0.80
Promoter methylation of E-cadherin, p16, and RAR-β(2) genes in breast tumors and dietary intake of nutrients important in one-carbon metabolism. Nutr Cancer (2011) 0.80
Differentially expressed microRNAs in postpartum breast cancer in Hispanic women. PLoS One (2015) 0.80
Coordinated regulation of p31(Comet) and Mad2 expression is required for cellular proliferation. Cell Cycle (2013) 0.79
Cell transformation assays for prediction of carcinogenic potential: state of the science and future research needs. Mutagenesis (2011) 0.79
Relationships among folate, alcohol consumption, gene variants in one-carbon metabolism and p16INK4a methylation and expression in healthy breast tissues. Carcinogenesis (2014) 0.79
Spontaneously immortalised bovine mammary epithelial cells exhibit a distinct gene expression pattern from the breast cancer cells. BMC Cell Biol (2010) 0.78
Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer. Breast Cancer (Auckl) (2016) 0.77
The C-terminus of interferon gamma receptor beta chain (IFNgammaR2) has antiapoptotic activity as a Bax inhibitor. Cancer Biol Ther (2009) 0.76
Mouse mammary gland is refractory to the effects of ethanol after natural lactation. Comp Med (2013) 0.76
HOXC8 regulates self-renewal, differentiation and transformation of breast cancer stem cells. Mol Cancer (2017) 0.75
Immortalization of T-cells is accompanied by gradual changes in CpG methylation resulting in a profile resembling a subset of T-cell leukemias. Neoplasia (2014) 0.75
Widespread Non-Canonical Epigenetic Modifications in MMTV-NeuT Breast Cancer. Neoplasia (2015) 0.75
Epigenetic Reprogramming of Lineage-Committed Human Mammary Epithelial Cells Requires DNMT3A and Loss of DOT1L. Stem Cell Reports (2017) 0.75
Epithelial cell senescence: an adaptive response to pre-carcinogenic stresses? Cell Mol Life Sci (2017) 0.75
Low p16(INK4a) Expression in Early Passage Human Prostate Basal Epithelial Cells Enables Immortalization by Telomerase Expression Alone. Prostate (2016) 0.75
Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol (2004) 101.91
The epigenomics of cancer. Cell (2007) 30.91
Cancer epigenetics comes of age. Nat Genet (1999) 12.63
Using GOstats to test gene lists for GO term association. Bioinformatics (2006) 12.58
The epigenetic progenitor origin of human cancer. Nat Rev Genet (2006) 9.65
Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res (1998) 8.95
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet (2000) 8.58
Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nat Genet (2006) 4.86
In situ analyses of genome instability in breast cancer. Nat Genet (2004) 4.32
Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res (1997) 4.02
Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature (2001) 3.58
Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. Proc Natl Acad Sci U S A (1985) 3.24
Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract. Proc Natl Acad Sci U S A (1984) 3.22
Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. Proc Natl Acad Sci U S A (2007) 2.91
Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvements. Nucleic Acids Res (2007) 2.80
Comprehensive DNA methylation profiling in a human cancer genome identifies novel epigenetic targets. Carcinogenesis (2006) 2.45
Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation. Oncogene (1998) 2.28
Agglomerative epigenetic aberrations are a common event in human breast cancer. Cancer Res (2008) 2.22
Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis. Clin Cancer Res (2007) 2.08
Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res (2003) 2.03
Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene (2001) 1.89
hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. Cancer Res (2007) 1.77
Overlapping probabilities of top ranking gene lists, hypergeometric distribution, and stringency of gene selection criterion. Conf Proc IEEE Eng Med Biol Soc (2006) 1.67
Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization. Genes Chromosomes Cancer (1997) 1.63
Epigenetic inactivation of the HOXA gene cluster in breast cancer. Cancer Res (2006) 1.63
Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene. Nucleic Acids Res (2007) 1.59
Inactivation of p53 function in cultured human mammary epithelial cells turns the telomere-length dependent senescence barrier from agonescence into crisis. Cell Cycle (2007) 1.40
Human epithelial cell immortalization as a step in carcinogenesis. Cancer Lett (2003) 1.38
Gradual phenotypic conversion associated with immortalization of cultured human mammary epithelial cells. Mol Biol Cell (1997) 1.37
Raf-1-induced growth arrest in human mammary epithelial cells is p16-independent and is overcome in immortal cells during conversion. Oncogene (2002) 1.32
High frequency of aberrant p16(INK4A) expression in human breast cancer. Am J Pathol (1996) 1.32
Epigenetic remodeling during arsenical-induced malignant transformation. Carcinogenesis (2008) 1.27
Transcriptional changes associated with breast cancer occur as normal human mammary epithelial cells overcome senescence barriers and become immortalized. Mol Cancer (2007) 1.24
Epigenetic inactivation of a cluster of genes flanking MLH1 in microsatellite-unstable colorectal cancer. Cancer Res (2007) 1.23
Cholera toxin stimulation of human mammary epithelial cells in culture. In Vitro (1982) 1.19
Chromosome analyses of human mammary epithelial cells at stages of chemical-induced transformation progression to immortality. Cancer Genet Cytogenet (1989) 1.18
Loss of p53 function accelerates acquisition of telomerase activity in indefinite lifespan human mammary epithelial cell lines. Oncogene (2003) 1.13
Array-based multiplex analysis of DNA methylation in breast cancer tissues. J Mol Diagn (2007) 1.07
Human mammary epithelial cells in culture: differentiation and transformation. Cancer Treat Res (1988) 1.06
Aberrant methylation of the maspin promoter is an early event in human breast cancer. Neoplasia (2004) 1.05
Morphologically normal-appearing mammary epithelial cells obtained from high-risk women exhibit methylation silencing of INK4a/ARF. Clin Cancer Res (2007) 1.05
GSTP1 promoter hypermethylation is an early event in breast carcinogenesis. Virchows Arch (2007) 1.05
Transformation of human mammary epithelial cells by oncogenic retroviruses. Cancer Res (1988) 1.03
Methylation of CpG islands of p16(INK4a) and cyclinD1 overexpression associated with progression of intraductal proliferative lesions of the breast. Hum Pathol (2008) 0.85
Cell type-specific DNA methylation patterns in the human breast. Proc Natl Acad Sci U S A (2008) 2.99
Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells. PLoS One (2010) 2.55
Molecular distinctions between stasis and telomere attrition senescence barriers shown by long-term culture of normal human mammary epithelial cells. Cancer Res (2009) 2.28
Agglomerative epigenetic aberrations are a common event in human breast cancer. Cancer Res (2008) 2.22
Human mammary progenitor cell fate decisions are products of interactions with combinatorial microenvironments. Integr Biol (Camb) (2008) 1.82
Epigenetic inactivation of the HOXA gene cluster in breast cancer. Cancer Res (2006) 1.63
Epigenetic silencing of DSC3 is a common event in human breast cancer. Breast Cancer Res (2005) 1.50
Characterization of hepatocellular carcinoma related genes and metabolites in human nonalcoholic fatty liver disease. Dig Dis Sci (2013) 1.48
Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression. Oncogene (2003) 1.48
Quantification of fetal DNA by use of methylation-based DNA discrimination. Clin Chem (2010) 1.45
Chromatin inactivation precedes de novo DNA methylation during the progressive epigenetic silencing of the RASSF1A promoter. Mol Cell Biol (2005) 1.45
Inactivation of p53 function in cultured human mammary epithelial cells turns the telomere-length dependent senescence barrier from agonescence into crisis. Cell Cycle (2007) 1.40
Raf-1-induced growth arrest in human mammary epithelial cells is p16-independent and is overcome in immortal cells during conversion. Oncogene (2002) 1.32
Molecular changes accompanying senescence and immortalization of cultured human mammary epithelial cells. Int J Biochem Cell Biol (2002) 1.32
Epigenetic regulation of normal human mammary cell type-specific miRNAs. Genome Res (2011) 1.27
Epigenetic remodeling during arsenical-induced malignant transformation. Carcinogenesis (2008) 1.27
Transcriptional changes associated with breast cancer occur as normal human mammary epithelial cells overcome senescence barriers and become immortalized. Mol Cancer (2007) 1.24
Accumulation of multipotent progenitors with a basal differentiation bias during aging of human mammary epithelia. Cancer Res (2012) 1.20
Different mutant/wild-type p53 combinations cause a spectrum of increased invasive potential in nonmalignant immortalized human mammary epithelial cells. Neoplasia (2008) 1.18
DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage. BMC Med Genomics (2008) 1.17
miRNA gene promoters are frequent targets of aberrant DNA methylation in human breast cancer. PLoS One (2013) 1.17
Self-organization is a dynamic and lineage-intrinsic property of mammary epithelial cells. Proc Natl Acad Sci U S A (2011) 1.11
Primary cilium-dependent and -independent Hedgehog signaling inhibits p16(INK4A). Mol Cell (2010) 1.08
Epigenetic mediated transcriptional activation of WNT5A participates in arsenical-associated malignant transformation. Toxicol Appl Pharmacol (2008) 1.08
Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations. Cell Cycle (2014) 1.05
Human pancreatic carcinoma cells activate maspin expression through loss of epigenetic control. Neoplasia (2003) 1.04
Arsenic toxicology: translating between experimental models and human pathology. Environ Health Perspect (2011) 1.03
Epigenetic regulation of maspin expression in human ovarian carcinoma cells. Gynecol Oncol (2006) 1.01
Monomethylarsonous acid produces irreversible events resulting in malignant transformation of a human bladder cell line following 12 weeks of low-level exposure. Toxicol Sci (2010) 1.01
The regulation of SOX7 and its tumor suppressive role in breast cancer. Am J Pathol (2013) 0.99
p53 induces distinct epigenetic states at its direct target promoters. BMC Genomics (2008) 0.96
ZNF652, a novel zinc finger protein, interacts with the putative breast tumor suppressor CBFA2T3 to repress transcription. Mol Cancer Res (2006) 0.95
Genetic and epigenetic inactivation of extracellular superoxide dismutase promotes an invasive phenotype in human lung cancer by disrupting ECM homeostasis. Mol Cancer Res (2011) 0.95
Arsenicals produce stable progressive changes in DNA methylation patterns that are linked to malignant transformation of immortalized urothelial cells. Toxicol Appl Pharmacol (2009) 0.94
The acetyltransferase p300/CBP-associated factor is a p53 target gene in breast tumor cells. Neoplasia (2004) 0.94
Processing of human reduction mammoplasty and mastectomy tissues for cell culture. J Vis Exp (2013) 0.92
Common chromosome fragile sites in human and murine epithelial cells and FHIT/FRA3B loss-induced global genome instability. Genes Chromosomes Cancer (2013) 0.92
Epigenetic regulation of the cell type-specific gene 14-3-3sigma. Neoplasia (2005) 0.92
Cellular senescence mediated by p16INK4A-coupled miRNA pathways. Nucleic Acids Res (2013) 0.90
Accumulation and altered localization of telomere-associated protein TRF2 in immortally transformed and tumor-derived human breast cells. Oncogene (2005) 0.89
Hypomethylation of the 14-3-3σ promoter leads to increased expression in non-small cell lung cancer. Genes Chromosomes Cancer (2011) 0.87
Maintenance of mitochondrial genomic integrity in the absence of manganese superoxide dismutase in mouse liver hepatocytes. Redox Biol (2013) 0.86
MnSOD up-regulates maspin tumor suppressor gene expression in human breast and prostate cancer cells. Antioxid Redox Signal (2003) 0.86
Caspase-independent cytochrome c release is a sensitive measure of low-level apoptosis in cell culture models. Aging Cell (2005) 0.84
Arsenic exposure induces the Warburg effect in cultured human cells. Toxicol Appl Pharmacol (2013) 0.84
Agglomerates of aberrant DNA methylation are associated with toxicant-induced malignant transformation. Epigenetics (2012) 0.84
Strategies for validation and testing of DNA methylation biomarkers. Epigenomics (2014) 0.83
Human Cell Surface Receptors as Molecular Imaging Candidates for Metastatic Prostate Cancer. Open Prost Cancer J (2009) 0.82
Karyotypic instability and centrosome aberrations in the progeny of finite life-span human mammary epithelial cells exposed to sparsely or densely ionizing radiation. Radiat Res (2008) 0.82
Cell-type specific DNA methylation patterns define human breast cellular identity. PLoS One (2012) 0.82
Flipping the epigenetic switch. Am J Pathol (2004) 0.80
Comparisons of PCR-based genome amplification systems using CpG island microarrays. Hum Mutat (2006) 0.80
Editorial: maspin as a molecular target for cancer therapy. J Urol (2003) 0.79
Optimal search-based gene subset selection for gene array cancer classification. IEEE Trans Inf Technol Biomed (2007) 0.79
In Vitro Assessment of the Inflammatory Breast Cancer Cell Line SUM 149: Discovery of 2 Single Nucleotide Polymorphisms in the RNase L Gene. J Cancer (2013) 0.78
Pharmacogenomics of the polyamine analog 3,8,13,18-tetraaza-10,11-[(E)-1,2-cyclopropyl]eicosane tetrahydrochloride, CGC-11093, in the colon adenocarcinoma cell line HCT1161. Technol Cancer Res Treat (2006) 0.77
Use of cell-free DNA in the investigation of intrauterine fetal demise and miscarriage. Obstet Gynecol (2015) 0.75